Abstract
The proliferative component of chronic myelomonocytic leukemia, related to an increased sensitivity of myeloid progenitors to granulocyte macrophage-colony stimulating factor, suggests dedicated therapeutic approaches.
Original language | English |
---|---|
Pages (from-to) | 3707-3709 |
Number of pages | 3 |
Journal | Clinical Cancer Research |
Volume | 22 |
Issue number | 15 |
DOIs | |
Publication status | Published - 1 Aug 2016 |